Showing 1 - 6 results of 6 for search 'Anthony L. Cunningham', query time: 0.04s Refine Results
  1. 1
    Vaccine profile of herpes zoster (HZ/su) subunit vaccine

    Vaccine profile of herpes zoster (HZ/su) subunit vaccine by Anthony L. Cunningham, Thomas Heineman

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Identifying HSV-1 Inhibitors from Natural Compounds via Virtual Screening Targeting Surface Glycoprotein D

    Identifying HSV-1 Inhibitors from Natural Compounds via Virtual Screening Targeting Surface Glycoprotein D by Jiadai Wu, Helen Power, Monica Miranda-Saksena, Peter Valtchev, Aaron Schindeler, Anthony L. Cunningham, Fariba Dehghani

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine

    Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine by John Litt, Robert Booy, Debra Bourke, Dominic E. Dwyer, Alan Leeb, Philip McCloud, Alicia N. Stein, Michael Woodward, Anthony L. Cunningham

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials

    Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials by Romulo Colindres, Valentine Wascotte, Alain Brecx, Christopher Clarke, Caroline Hervé, Joon Hyung Kim, Myron J. Levin, Lidia Oostvogels, Toufik Zahaf, Anne Schuind, Anthony L. Cunningham

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials

    The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials by Joon Hyung Kim, John Diaz-Decaro, Ning Jiang, Shinn-Jang Hwang, Eun Ju Choo, Maribel Co, Andrew Hastie, David Shu Cheong Hui, Junya Irimajiri, Jacob Lee, Edward Man-Fuk Leung, Haiwen Tang, Tomomi Tsuru, Philip Watson, Zhenhua Wu, Chong-Jen Yu, Yanfei Yuan, Toufik Zahaf, Anthony L. Cunningham, Anne Schuind

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials

    Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials by Lidia Oostvogels, Thomas C. Heineman, Robert W. Johnson, Myron J. Levin, Janet E. McElhaney, Peter Van den Steen, Toufik Zahaf, Alemnew F. Dagnew, Roman Chlibek, Javier Diez-Domingo, Iris S. Gorfinkel, Caroline Hervé, Shinn-Jang Hwang, Hideyuki Ikematsu, George Kalema, Himal Lal, Shelly A. McNeil, Tomas Mrkvan, Karlis Pauksens, Jan Smetana, Daisuke Watanabe, Lily Yin Weckx, Anthony L. Cunningham

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: